The Melanoma Hub – Home Forums Immunotherapy Expectations for therapy Adjuvant Immunotherapy in stage IIIA patients Reply To: Adjuvant Immunotherapy in stage IIIA patients

Expert Nurse
Avatar photoMollie Reed

    This is certainly an interesting approval given that IIIA patients weren’t included in the trial. While we have yet to encroach this in practice, I think that this will be decided on a case-by-case basis. For example, I think that if you see a younger, healthier patient, oncologists are going to want to be more aggressive in the adjuvant setting. As with everything, it will end up being about weighing risks and benefits. I am happy that more patients than just those eligible for the trial can potentially benefit from this, but it certainly creates some gray areas!